Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children

Rocío Quiroga1, Esther Nistal1,2, Brisamar Estébanez2

  • 1Complejo Asistencial Universitario (CAULE), León, Spain.

Insights

Childhood obesity intervention through combined exercise training improved gut microbiota and reduced inflammation in obese children. This physical activity approach offers a non-pharmacological therapy for pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Microbiome Research
  • Exercise Physiology

Background:

  • Childhood obesity is a growing epidemic linked to metabolic syndrome and gut dysbiosis.
  • Physical exercise is recognized for its potential to combat obesity and influence gut microbiota.
  • Understanding the impact of exercise on the gut microbiome in obese children is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the effects of a 12-week combined strength and endurance training program on the gut microbiota and inflammation in obese pediatric patients.
  • To analyze changes in anthropometric, biochemical, muscular strength, and inflammatory markers.
  • To assess alterations in bacterial composition, functionality, and associated metabolic pathways.

Main Methods:

  • Randomized controlled trial involving 39 obese children, divided into control and training groups.
  • Evaluation of anthropometric and biochemical parameters, muscular strength, and inflammatory signaling pathways (NLRP3).
  • Metagenomic sequencing and metabolomic analysis to determine gut microbiota composition and functionality.

Main Results:

  • The exercise group showed reduced plasma glucose and increased dynamic strength compared to the control group.
  • Metagenomic analysis revealed exercise counteracted obesity-associated bacterial profiles, decreasing Proteobacteria and increasing beneficial genera like Blautia.
  • Metabolomic analysis indicated exercise-induced changes in short-chain fatty acids and sugars, correlating with microbiota shifts and inhibited NLRP3 pathway activation.

Conclusions:

  • A 12-week exercise intervention positively modulated the gut microbiota profile in obese children, shifting it towards a healthier state.
  • Exercise training effectively reduced obesity-related inflammation by inhibiting the NLRP3 signaling pathway, likely through microbiota modulation.
  • Combined strength and endurance training represents a promising non-pharmacological therapeutic strategy for managing childhood obesity and its associated health risks.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
109
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
149
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
545